Literature DB >> 10903592

Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience.

J I Tsao1, Y Nimura, J Kamiya, N Hayakawa, S Kondo, M Nagino, M Miyachi, M Kanai, K Uesaka, K Oda, R L Rossi, J W Braasch, J M Dugan.   

Abstract

OBJECTIVE: To compare the experience and outcome in the management of hilar cholangiocarcinoma at one American and one Japanese medical center. SUMMARY BACKGROUND DATA: Controversies surround the issues of extent of resection for hilar cholangiocarcinoma and whether the histopathology of such cancers are similar between patients treated in America and in Japan.
METHODS: Records were reviewed of 100 patients treated between 1980 and 1995 at the Lahey Clinic in the United States, and of 155 patients treated between 1977 and 1995 at Nagoya University Hospital in Japan. Selected pathologic slides of resected cancers were exchanged between the two institutions and reviewed for diagnostic concordance.
RESULTS: In the Lahey cohort, there were 25 resections, 53 cases of surgical exploration with biliary bypass or intubation, and 22 cases of percutaneous transhepatic biliary drainage or endoscopic biliary drainage without surgery. In the Nagoya cohort, the respective figures were 122, 10, and 23. The overall 5-year survival rate of all patients treated (surgical and nonsurgical) during the study periods was 7% in the Lahey cohort and 16% in the Nagoya cohort. The overall 10-year survival rates were 0% and 12%, respectively. In patients who underwent resection with negative margins, the 5- and 10-year survival rates were 43% and 0% for the Lahey cohort and 25% and 18% for the Nagoya cohort. The surgical death rate for patients undergoing resection was 4% for Lahey patients and 8% for Nagoya patients. Of the patients who underwent resection, en bloc caudate lobectomy was performed in 8% of the Lahey patients and 89% of the Nagoya patients. Histopathologic examination of resected cancers showed that the Nagoya patients had a higher stage of disease than the Lahey patients.
CONCLUSIONS: In both Lahey and Nagoya patients, survival was most favorable when resection of hilar cholangiocarcinoma was accomplished with margin-negative resections. Combined bile duct and liver resection with caudate lobectomy contributed to a higher margin-negative resection rate in the Nagoya cohort.

Entities:  

Mesh:

Year:  2000        PMID: 10903592      PMCID: PMC1421125          DOI: 10.1097/00000658-200008000-00003

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  37 in total

1.  Percutaneous transhepatic biliary drainage in patients with malignant biliary obstruction of the hepatic confluence.

Authors:  M Nagino; N Hayakawa; Y Nimura; M Dohke; S Kitagawa
Journal:  Hepatogastroenterology       Date:  1992-08

Review 2.  Research into the results of resection of hilar bile duct cancer.

Authors:  E J Boerma
Journal:  Surgery       Date:  1990-09       Impact factor: 3.982

3.  Combined portal vein and liver resection for carcinoma of the biliary tract.

Authors:  Y Nimura; N Hayakawa; J Kamiya; S Maeda; S Kondo; A Yasui; S Shionoya
Journal:  Br J Surg       Date:  1991-06       Impact factor: 6.939

4.  Hepatopancreatoduodenectomy for advanced carcinoma of the biliary tract.

Authors:  Y Nimura; N Hayakawa; J Kamiya; S Maeda; S Kondo; A Yasui; S Shionoya
Journal:  Hepatogastroenterology       Date:  1991-04

5.  Management strategies in resection for hilar cholangiocarcinoma.

Authors:  H Bismuth; R Nakache; T Diamond
Journal:  Ann Surg       Date:  1992-01       Impact factor: 12.969

6.  Clinicopathologic studies on perineural invasion of bile duct carcinoma.

Authors:  M R Bhuiya; Y Nimura; J Kamiya; S Kondo; S Fukata; N Hayakawa; S Shionoya
Journal:  Ann Surg       Date:  1992-04       Impact factor: 12.969

7.  Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus.

Authors:  Y Nimura; N Hayakawa; J Kamiya; S Kondo; S Shionoya
Journal:  World J Surg       Date:  1990 Jul-Aug       Impact factor: 3.352

8.  Surgical management of 552 carcinomas of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded). Results of the French Surgical Association Survey.

Authors:  R Reding; J L Buard; G Lebeau; B Launois
Journal:  Ann Surg       Date:  1991-03       Impact factor: 12.969

9.  Carcinoma of the extrahepatic bile ducts: results of an aggressive surgical approach.

Authors:  J C Langer; B Langer; B R Taylor; R Zeldin; B Cummings
Journal:  Surgery       Date:  1985-10       Impact factor: 3.982

10.  Surgical treatment for carcinoma at the confluence of the major hepatic ducts.

Authors:  Y Iwasaki; T Okamura; A Ozaki; T Todoroki; Y Takase; K Ohara; A Nishimura; H Otsu
Journal:  Surg Gynecol Obstet       Date:  1986-05
View more
  75 in total

1.  [Hilar cholangiocarcinoma -- results of en bloc resection of tumor and liver].

Authors:  G Otto; J Thies; M Hoppe-Lotichius; F Bittinger; M B Pitton; A Hadian
Journal:  Chirurg       Date:  2004-01       Impact factor: 0.955

2.  Impaired expression of hepatic multidrug resistance protein 2 is associated with posthepatectomy hyperbilirubinemia in patients with biliary cancer.

Authors:  Tatsuharu Yamada; Toshiyuki Arai; Masato Nagino; Koji Oda; Junichi Shoda; Hiroshi Suzuki; Yuichi Sugiyama; Yuji Nimura
Journal:  Langenbecks Arch Surg       Date:  2005-06-17       Impact factor: 3.445

3.  Management of hilar cholangiocarcinoma in the North of England: pathology, treatment, and outcome.

Authors:  S D Mansfield; O Barakat; R M Charnley; B C Jaques; C B O'Suilleabhain; P J Atherton; D Manas
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

4.  Outcome of surgical treatment of hilar cholangiocarcinoma.

Authors:  Kazuhiro Otani; Kazuo Chijiiwa; Masahiro Kai; Jiro Ohuchida; Motoaki Nagano; Kazuyo Tsuchiya; Kazuhiro Kondo
Journal:  J Gastrointest Surg       Date:  2007-12-18       Impact factor: 3.452

5.  Surgical management of hilar cholangiocarcinoma: the Nagoya experience.

Authors:  Hideki Nishio; Masato Nagino; Yuji Nimura
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

6.  Principles of surgical resection in hilar cholangiocarcinoma.

Authors:  Emilio Ramos
Journal:  World J Gastrointest Oncol       Date:  2013-07-15

7.  Clinical Value of Inflammation-Based Prognostic Scores to Predict the Resectability of Hyperbilirubinemia Patients with Potentially Resectable Hilar Cholangiocarcinoma.

Authors:  Hai-Jie Hu; Yan-Wen Jin; Rong-Xing Zhou; Wen-Jie Ma; Qin Yang; Jun-Ke Wang; Fei Liu; Nan-Sheng Cheng; Fu-Yu Li
Journal:  J Gastrointest Surg       Date:  2018-08-03       Impact factor: 3.452

8.  Surgical treatment of hilar bile duct carcinoma: experience with 25 consecutive hepatectomies.

Authors:  Yoshifumi Kawarada; Bidhan C Das; Tatsushi Naganuma; Masami Tabata; Hiroki Taoka
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

9.  Resection of hilar cholangiocarcinomas: pivotal prognostic factors and impact of tumor sclerosis.

Authors:  Harald Puhalla; Thomas Gruenberger; Herwig Pokorny; Thomas Soliman; Fritz Wrba; Ulrike Sponer; Thomas Winkler; Meinhard Ploner; Markus Raderer; Rudolf Steininger; Ferdinand Mühlbacher; Friedrich Laengle
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

Review 10.  Staging of extrahepatic cholangiocarcinoma.

Authors:  Yong Eun Chung; Myeong-Jin Kim; Young Nyun Park; Yoon-Hee Lee; Jin-Young Choi
Journal:  Eur Radiol       Date:  2008-05-06       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.